Cargando…
Targeting Splicing in the Treatment of Human Disease
The tightly regulated process of precursor messenger RNA (pre-mRNA) alternative splicing (AS) is a key mechanism in the regulation of gene expression. Defects in this regulatory process affect cellular functions and are the cause of many human diseases. Recent advances in our understanding of splici...
Autores principales: | Suñé-Pou, Marc, Prieto-Sánchez, Silvia, Boyero-Corral, Sofía, Moreno-Castro, Cristina, El Yousfi, Younes, Suñé-Negre, Josep Mª, Hernández-Munain, Cristina, Suñé, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368691/ https://www.ncbi.nlm.nih.gov/pubmed/28245575 http://dx.doi.org/10.3390/genes8030087 |
Ejemplares similares
-
Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy
por: Suñé-Pou, Marc, et al.
Publicado: (2018) -
Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease
por: Suñé-Pou, Marc, et al.
Publicado: (2020) -
Comparative Analysis of the Physicochemical and Biological Characteristics of Freeze-Dried PEGylated Cationic Solid Lipid Nanoparticles
por: Narváez-Narváez, David A., et al.
Publicado: (2023) -
ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery
por: Hueso, Miguel, et al.
Publicado: (2021) -
Prp40 pre-mRNA processing factor 40 homolog B (PRPF40B) associates with SF1 and U2AF(65) and modulates alternative pre-mRNA splicing in vivo
por: Becerra, Soraya, et al.
Publicado: (2015)